Coronavirus News and Research

RSS

People with obesity overrepresented among COVID-19 patients receiving intensive care

People with obesity were overrepresented among adults in Sweden receiving intensive care for COVID-19 during the first wave of the pandemic. Just over 39 percent had obesity, compared with some 16 percent in the population.

18 Oct 2021

Research indicates that mRNA vaccine-induced T cells respond robustly to new SARS-CoV-2 variants

To address the gaps in the knowledge, a team of researchers from the University of California and the Gladstone Institute of Virology conducted 39-parameter phenotyping by cytometry by time of flight (CyTOF) on 33 longitudinal specimens from 11 mRNA-vaccinated individuals, of which six had previously been infected and recovered from COVID-19.

18 Oct 2021

Delta and Delta Plus infect lung cells with higher efficiency than the original virus, research shows

The emergence of new SARS-CoV-2 variants that can spread rapidly and undermine vaccine-induced immunity threatens the end of the COVID-19 pandemic. The delta variant (B.1.617.2) emerged in India and subsequently spread globally within a short time period. Also in Germany, almost all recent infections are due to this variant.

18 Oct 2021

Does vitamin D deficiency increase the risk of SARS-CoV-2 infections?

A recent study posted to the medRxiv* preprint server attempted to understand the relationship between vitamin D levels and COVID-19 by studying a population of UK healthcare workers who exhibited symptoms for COVID-19.

17 Oct 2021

Serologic testing algorithm to detect disparities in SARS-CoV-2 infection prevalence and vaccination uptake

A new study recently published on the medRxiv* preprint server demonstrates the use of a serological testing algorithm for identifying disparities in infection rates and vaccine uptake amongst the study population to enable public health interventions.

17 Oct 2021

Fibrin immunotherapy may resolve blood clotting induced by SARS-CoV-2

A group of researchers from the United States discovered that the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce the formation of highly inflammatory blood clots amenable to neutralization by a fibrin-targeting monoclonal antibody – opening the door for a completely new strategy to reduce thrombotic inflammation in coronavirus disease 2019 (COVID-19).

17 Oct 2021

Mix-and-match booster shots beneficial in boosting SARS-CoV-2 immunity

Should you get a second dose of the same vaccine if you’ve received the one-dose Johnson & Johnson shot? According to new clinical trial results published on the preprint medRxiv* server, a booster shot of a messenger RNA (mRNA) vaccine may increase your chances of neutralizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Oct 2021

Researchers identify common side effects of three COVID-19 vaccines

COVID-19 vaccines remain the best tool in the pandemic toolbox against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). But they are not perfect; reports have surfaced of mild to severe side effects after vaccination. A new study from researchers in the Lampe & Company GmbH & Co. KG compared the severity of adverse events from each coronavirus vaccine.

17 Oct 2021

Phase 1 open-label trial shows SARS-CoV-2 DNA vaccine induces durable immune response

The efficacy and safety of a DNA-based vaccine are investigated, finding that the unique vaccine imparts a robust and long-lasting immunogenic response.

15 Oct 2021

Schedule online visits first? It’s the next big thing in health insurance

At the height of the covid-19 pandemic, people often relied on telemedicine for doctor visits. Now, insurers are betting that some patients liked it enough to embrace new types of health coverage that encourages video visits — or outright insists on them.

15 Oct 2021

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

The results of a phase 2 clinical trial featuring a SARS-CoV-2 recombinant protein vaccine developed by GlaxoSmithKline are reported, demonstrating a favorable immune response amongst both naïve and non-naïve adults with an acceptable safety profile.

15 Oct 2021

The military as a disease vector and COVID-19

A recent systematic review aimed to study existing evidence for the military being a historically relevant disease vector that has been overlooked during the COVID-19 pandemic.

15 Oct 2021

Study detects the presence of SARS-CoV-2 in semen along with low sperm count

A new study reported findings of semen analysis from a prospective COVID-19 cohort study.

15 Oct 2021

Study finds menstrual bleeding changes after SARS-CoV-2 vaccination

A new study investigated menstrual bleeding patterns among current and former menstruating people, based on the premise that these bleeding changes were associated with changes in clotting or inflammation, which can affect the normal menstrual repair.

15 Oct 2021

Nasal photodisinfection therapy for COVID-19 patients may reduce the severity of lower tract respiratory disease

Research on the efficacy of nasal photodisinfection therapy for treating asymptomatic and early stage COVID-19 patients has found that it may reduce the severity of lower tract respiratory disease.

15 Oct 2021

Eligible fully vaccinated passengers arriving in England can take a cheaper lateral flow test

Eligible fully vaccinated passengers arriving in England from countries not on the red list can take a lateral flow test on or before day 2 of their arrival from October 24, rather than PCR tests - cutting the cost of tests in time for travelers returning from half term breaks.

14 Oct 2021

SARS-CoV-2 outbreak in Delhi highlights challenge of reaching herd immunity against Delta

The severe outbreak of COVID-19 in Delhi, India, in 2021 showed not only that the Delta variant of SARS-CoV2 is extremely transmissible but that it can infect individuals previously infected by a different variant of the coronavirus, say a team of international scientists writing in Science.

14 Oct 2021

Coronavirus News and Research

People with obesity overrepresented among COVID-19 patients receiving intensive care

Research indicates that mRNA vaccine-induced T cells respond robustly to new SARS-CoV-2 variants

Delta and Delta Plus infect lung cells with higher efficiency than the original virus, research shows

Does vitamin D deficiency increase the risk of SARS-CoV-2 infections?

Serologic testing algorithm to detect disparities in SARS-CoV-2 infection prevalence and vaccination uptake

Fibrin immunotherapy may resolve blood clotting induced by SARS-CoV-2

Mix-and-match booster shots beneficial in boosting SARS-CoV-2 immunity

Researchers identify common side effects of three COVID-19 vaccines

Phase 1 open-label trial shows SARS-CoV-2 DNA vaccine induces durable immune response

Schedule online visits first? It’s the next big thing in health insurance

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

The military as a disease vector and COVID-19

Study detects the presence of SARS-CoV-2 in semen along with low sperm count

Study finds menstrual bleeding changes after SARS-CoV-2 vaccination

Nasal photodisinfection therapy for COVID-19 patients may reduce the severity of lower tract respiratory disease

Eligible fully vaccinated passengers arriving in England can take a cheaper lateral flow test

SARS-CoV-2 outbreak in Delhi highlights challenge of reaching herd immunity against Delta

Covid testing, turnaround times are still uneven this far into pandemic

KHN’s ‘What the Health?’: The politics of vaccine mandates

Study of the impact of school openings on the spread of COVID-19 in the US

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News